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Summary There is increasing interest in the use of microspheres, loaded with chemotherapeutic agents, for
regional therapy to hepatic metastases. It is necessary to deliver these particles predominately to tumour rather
than to normal liver. This study investigates factors influencing the distribution of regionally injected
microspheres. Discreet tumour was induced in rats by subcapsular hepatic inoculations of HSN cells. At 20
days, 12.5 ftm, 25 pm or 40pm diameter, radiolabelled albumin microspheres were administered, in various
concentrations, via the gastroduodenal artery. Tumour to normal liver microsphere distribution ratios were
determined and median values ranged from 0.1 (0.2mg ml-' 12.5#Lm microspheres) to 1.8 (20mg ml 40pm
microspheres). Concentrated suspensions (20 mg ml-') of large microspheres (40gm) produced the most
favourable tumour to normal liver distribution ratios. These results not ony have implications for the
therapeutic administration of microspheres but also for their use in blood-flow studies.
In view of the generally disappointing results which have
been reported with systemic therapy for colorectal liver meta-
stases, interest has been stimulated in the concept of regional
treatment. Several types of embolic particle, such as radio-
active glass microspheres (Herba et al., 1988) and drug-
loaded microcapsules and microspheres (Kato et al., 1981;
McArdle et al., 1988), have been administered, via hepatic
artery catheters, with encouraging effects.
It is desirable to delivery these particles predominately to
tumour, rather than normal tissues, thereby achieving maxi-
mum efficacy and minimum toxicity. Previous studies have
assumed that particles, administered via the hepatic artery,
are distributed in proportion to the relative arterial blood
flow to the normal liver and the hepatic metastases. Further-
more, the distribution of regionally administered radiolabell-
ed macroaggregated albumin has been employed to assess
blood flow in tumour relative to flow in normal liver (Daly et
al., 1985). However, the assumption that all embolising par-
ticles are distributed in proportion to blood flow has not
been tested. Variations in size, shape, composition and con-
centration of microspheres or microcapsules might influence
their distribution.
The aim of the present study was to investigate the effects
of microsphere diameter and concentration on the propor-
tions of a regionally administered albumin microsphere bolus
reaching normal liver and hepatic tumour.
Materials and methods
Animal model
Male, Hooded-Lister rats, weighting 150-200 g, received an
intraperitoneal pentobarbitone (60 mg kg-') general anesthe-
tic. Through a short, midline incision, the liver was inocu-
lated subcapsularly with 106 HSN sarcoma cells into the
median and the left lobes (one inoculation per lobe). The
HSN sarcoma was originally induced in a male Hooded rat
with 3-4-benzyprene (Currie & Gage, 1973). All subsequent
experiments were undertaken at 20 days when macroscopic
tumour, which was hypovascular relative to normal liver
(Hemingway et al., 1991) was present. Tumour blood flow is
entirely arterial with no portal venous component (unpub-
lished data).
Microsphere preparation
Microspheres were prepared as previously described (Will-
mott et al., 1985). Briefly, human serum albumin (190 mg)
was added to 1Omg 125I iodinated albumin (1 mCi) (Amer-
sham International) and dissolved in 1 mM phosphate buffer
containing 0.1% sodium dodecyl sulphate (0.4 ml) then dilut-
ed with water (0.5 ml). The resulting solution was emulsified
in an oil phase of cottonseed oil/petroleum ether and the
protein was cross-linked with gluteraldehyde (100 iLl, 12.5%)
to stabilise the microspheres. Different sizes of microspheres
were obtained by altering the stirring rate over the range
1,200-2,700 r.p.m. during the formation of the water-in-oil
emulsion. After consecutive differential centrifugation steps
in petroleum ether, isopropanol and PBS + 0.5% Tween 80
to remove particles smaller than 3 tsm, the volume-weighted
mean microsphere diameter was 12.5, 25 or 40 ftm as assessed
by laser diffraction measurements. Eighty per cent of micro-
spheres were in the ranges 3-19, 8-39 and 18-54 tLm for the
12.5, 25 and 40 tsm microspheres respectively.
Following washing in physiological saline, microspheres
were ready for use. More than 99% of activity was associ-
ated with microspheres. Microspheres were then suspended in
0.9% saline with 0.01% Tween 80 in concentrations of 0.2, 2
and 20 mgml-' for each diameter of microsphere. There
were 2.7 x 106, 1.2 x 107 and 9.2 x 107 microspheres/ml in
the 20mgml-l suspensions of the 40, 25 and 12.5tsm dia-
meter microspheres respectively. Microsphere in vivo half-life
in rat liver is 3.6 days. 1251 leaching is only 1.6% at 9 days
when microspheres are incubated at 37°C in rat serum (Will-
mott et al., 1989).
Smaller diameter particles were avoided since they would
be expected to pass through the hepatic capillary bed and
into the systemic circulation. More dilute suspensions were
not used since these would result in insufficient radioactivity
in tissue samples to allow accurate measurement in the
gamma counter.
Regional administration ofmicrospheres
Under intraperitoneal pentobarbitone general anaesthetic,
a polythene cannula was inserted into the gastroduodenal
artery and held with a silk ligature so that its tip lay just
distal to its origin from the hepatic artery. Flow in the
hepatic artery was observed not to be obstructed by the
cannula. Radiolabelled, albumin microspheres were suspend-
ed with a rotamixer for 1 min than a 50 pl aliquot of this
suspension was drawn up into a 100 ll HPLC syringe and
injected via the cannula into the hepatic artery over 20s.
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Groups of six animals received each microsphere size/concen-
tration combination as shown in Table I. Five minutes after
microsphere injection, the rat was humanely killed. Liver,
lungs, spleen, stomach, kidneys and intestines were removed
and the normal liver and tumour were weighed. The HPLC
syringe was flushed into a counting vial.
Assessment ofmicrosphere distribution
Radioactivity in excised organs, syringe washings and the
gastroduodenal artery cannula was measured in a gamma
well counter (Packard 500C). Entire organs were counted.
The percentage of microspheres entering the animal (%a)
was calcuated using the following equation:
/a total activity in organs x 100 o total activity in organs, syringe and catheter
The percentage of microspheres entering the animal and
embolising in the liver (%b) was expressed as:
%b = total activity in liver x 100
total activity in liver, stomach, bowel, spleen, kidney and lung
Experiments where excessive numbers of microspheres had
either failed to enter the animal or had flowed retrogradely in
the hepatic artery were rejected.
Shunting of microspheres to the pulmonary circulation
through the hepatic vascular bed (%c) was calculated from
the equation:
%c _ total activity in lungs x 100
%c total activity in liver and lungs
The relative number of microspheres per gram of tissue in
tumour and normal liver (T/N ratio) was calculated from the
amount of radioactivity in each sample.
Statistical analysis
The effects ofmicrosphere concentration and size on the T/N
ratio and percent hepatic microsphere entrapment were
studied using the Kruskal-Wallis test. The effect of tumour
weight on T/N ratio was studied using linear regression
analysis. A P value of 0.05 or less was considered significant.
Results
Liver metastases model
Tumour was present in all animals at 20 days. Six animals
only grew tumour at one of the two HSN inoculation sites.
The mean weight of individual tumours was 2.05 g (s.d. 1.17)
and the total tumour weight per animal averaged 3.83 g (s.d.
1.92).
Microsphere administration
An. average of 89% (s.d. 7) of administered microspheres
entered the animal (%a), of which 94% (s.d. 8) were trapped
in the liver or tumour (%b). The percentage of microspheres
Table I
Microsphere Albumin Tumour
diameter concentration weight (g) TIN ratio
("im) (mgml') n median (range) median (range)
[ 0.2 6 5.0 (2.9-9.6) 0.1 (0.03-0.2)
12.5 [2 6 4.5 (2.5-6.2) 0.5 (0.1-1.3)
20 6 3.3(2.2-6.7) 0.5(0.3-1.2)
- 0.2 6 4.1 (1.6-8.6) 0.1 (0.01-0.2)
25 2 6 2.9 (2.0-6.6) 0.8 (0.1-1.2)
20 6 1.8 (0.5-4.6) 1.4(1.2-2.7)
[ 0.2 6 2.6(0.9-4.1) 0.3 (0.03-1.1)
40 2 6 3.7 (1.9-5.3) 0.5 (0.1-1.3)
20 6 3.7(2.5-6.2) 1.8(1.2-2.7)
that entered the liver did not vary significantly with either
microsphere concentration or size.
Shunting to the lungs (%c) was less than 0.5% in 41 out of
54 animals and in the remaining 13 animals ranged from 1 to
4%. Shunting of 1% or more occurred more frequently in
animals that received the smallest size of microspheres (10
out of 18) than in the other groups (2/18 and 1/18 for 25 and
40jim microspheres respectively), but there was no associa-
tion between shunting and either microsphere concentration
or tumour weight.
T/N ratios
T/N ratios for the various experimental groups are shown in
Table I and Figure 1. For each size ofmicrospheres, the T/N
ratio varied significantly with concentration (Kruskal-Wallis;
P=0.013, P=0.0009, P=0.004 for 12.5, 25 and 40 im
respectively), with the median T/N ratio increasing with con-
centration in each instance.
The effect on T/N ratios of varying the diameter of the
microspheres at a fixed concentration was significant only
at the highest concentration (Kruskal-Wallis, P = 0.11,
P =0.81, P = 0.004 for 0.2, 2 and 20mgml' respectively).
Figure 2 shows the relationship between T/N ratios and
total tumour weight for three concentrations ofmicrospheres.
Different diameters are not distinguished for clarity and
because the influence of diameter on T/N ratios was rela-
tively weak. Combining all groups, there is a weak but
statistically significant negative correlation between T/N ratio
and tumour weight (r = - 0.36, P<0.01). Despite the fact
that animals receiving the most concentrated microspheres
tended to have lower tumour weights than those receiving the
most dilute suspension, the effect of concentration on T/N
ratio is not purely due to imblance between groups with
respect to tumour weight. Similarly, it is clear that the effect
of microsphere diameter on T/N ratio at the 20mgml'
concentration cannot be explained by tumour weight varia-
tion (Table I).
Discussion
Precise knowledge of the distribution of regionally admini-
stered embolic particles is required for two reasons. First, it
is desirable to optimise the proportion of a given dose of
therapeutic microspheres which lodges in tumour rather than
normal tissue. Maximum treatment efficacy can therefore be
expected with minimum toxicity. For example, Meade and
co-authors (1987) studied the distribution of microspheres
which were injected into the rat's ascending aorta and recom-
mended that 32.5jim was the optimum diameter for region-
ally administered therapeutic radioactive microspheres.
Secondly, the validity of perfusion studies for assessing
tumour blood flow must be verified; particularly if manage-
ment decisions are to be based on the results of such inves-
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tigations. Several studies have shown that patients with
hypervascular liver metastases have an improved response to
regional chemotherapy compared to those with hypovascular
tumours (Kim et al., 1977; Kaplan et al., 1980; Daly et al.,
1985; Civalleri et al., 1989). Daly and co-authors (1985) have
suggested that selection of colorectal hepatic metastases
patients for regional chemotherapy might be guided by the
results of '"Tc-MAA perfusion studies. It is therefore impor-
tant to establish whether the results of such investigations
actually correspond with the subsequent distribution of
regionally administered therapeutic agents.
Previous studies of the distribution of various sizes of
microspheres have used injection via the ascending aorta
(Meade et al., 1987). However, targetted therapy utilises
administration of microspheres via the hepatic artery and we
therefore employed this route ofdelivery in the present study.
There were consistent differences in T/N ratio across the
range of concentrations for all microsphere sizes and across
the range of sizes for the 20 mgml-' concentration.
The reasons for the observed differences in T/N ratios are
not understood at present. We do not know whether the
distribution of large, concentrated or small, dilute micro-
spheres more accurately reflects hepatic arterial flow but it
would be natural to expect the latter to produce the least
disturbance in pre-existing haemodynamic conditions. It is
possible, however, that the T/N ratios for small dilute micro-
spheres underestimate the true blood flow ratio because of
the plasma skimming effect. Some human hepatic perfusion
studies have employed 2.5 mg of 9'Tc labelled albumin
microspheres (23-45 ,Lm diameter) in a concentration of 1.25
mgml-': roughly equivalent to the dilute suspensions in the
animal model in the present study (Goldberg et al., 1987).
The flow disturbance following administration of concen-
trated microspheres could be likened to the effects of degrad-
able starch microspheres. Dynamic flow scintigraphic studies
have revealed flow dislocation from areas ofhigh resting flow
to those with low resting flow following administration of
45-90 x 106 of these 40pm particles in a volume of 50 ml
(Civalleri et al., 1989). Microspheres which are administered
early in a concentrated infusion might tend to go to high
flow areas resulting in embolisation which leads to distribu-
tion of the latter portion of microspheres to relatively hypo-
vascular areas. A comparision of regional microsphere distri-
bution with other methods ofliver blood flow assessment, for
example the reference microsphere technique (Malik et al.,
1976), might clarify this issue.
Vascularity has been demonstrated to vary with tumour
size (Ackerman, 1974). Higher T/N ratios are associated with
smaller tumours and larger tumours tend to become avas-
cular in their core. However, in the present study there was
no evidence that observed differences in T/N ratios between
experimental groups could be entirely accounted for by
differences in tumour size between groups.
Large, concentrated microspheres produced the highest T/
N ratios. Could larger particles in more concentrated suspen-
sions give even better ratios? Unfortunately, this question
could not be answered since we were unable to administer
larger (50pm) or more concentrated (40 mg ml-') micro-
spheres in the present study because of the narrow diameter
of the gastroduodenal artery in this animal model.
Enhancement of the T/N ratio may be achieved with drug-
induced modification of liver blood flow. Vasoconstrictors
have similar effects to those proposed for starch microspheres
in that they redistribute flow away from parenchymal vessels
therefore creating pooling in the lacunar circulation of the
tumour vasculature. A vasoactive agent, such as angiotensin
II, may be used to induce vasoconstriction in normal liver
whilst tumour vessels, which lack smooth muscle, remain
dilated. Therefore microspheres which are administered after
angiotensin II are targetted to tumour (Goldberg et al.,
1987). It remains to be seen whether the optimum T/N ratio
achieved with the large, concentrated microspheres can be
potentiated with vasoactive agents.
In conclusion, large, concentrated microspheres are assoc-
iated with relatively high T/N ratios. Therefore, delivery of a
concentrated suspension of large microspheres with a rela-
tively low drug pay load might be desirable for regional
therapy. Furthermore, hepatic arterial perfusion studies
should be interpreted with caution. If therapy is to be guided
by the results of such studies, the materials used for per-
fusion scans should resemble those that are to be used for
treatment as closely as possible. Further studies should inves-
tigate the relationship between regional microsphere adminis-
tration and blood flow.
The authors are grateful to Dr G.D. Murray for his advice regarding
the anaylsis and presentation of the data. This project was supported
by the Cancer Research Campaign, the Scottish Home and Health
Department, the Medical Research Council and the Association for
International Cancer Research. We are grateful to Helen Logan for
assistance with microsphere production.
References
ACKERMAN, N.B. (1974). The blood supply of experimental liver
metastases. IV. Changes in vascularity with increasing tumour
growth. Surgery, 75, 589.
CIVALLERI, D., SCOPINARO, G., BALLETTO, N. & 5 others (1989).
changes in vascularity of liver tumour after hepatic arterial embo-
lisation with degradable starch microspheres. Br. J. Surg., 76,
699.
CURRIE, G.A. & GAGE, J.O. (1973). Influence of tumour growth on
the evoluation of cytotoxic lymphoid cells in rats bearing a
spontaneously metastasizing syngeneic fibrosarcoma. Br. J.
Cancer, 28, 136.
DALY, J.M., BUTLER, J., KEMENY, N. & 6 others (1985). Predicting
tumor response in patients with colorectal hepatic metastases.
Ann. Surg., 202, 384.
GOLDBERG, J.A., BRADNAM, M.S., KERR, D.J. & 5 others (1987).
Single photon emission computed tomographic studies (SPECT)
of hepatic arterial perfusion scintigraphy (HAPS) in patients with
colorectal liver metastases: improved tumour targeting by micro-
spheres with angiotension II. Nucl. Med. Commun., 8, 1025.
HEMINGWAY, D.M., COOKE, T.G., GRIME, S.J., NOTT, D.M. & JEN-
KINS, S.A. (1991). Changes in hepatic haemodynamics and
hepatic perfusion index during the growth and development of
hypovascular HSN sarcoma in rats. Br. J. Surg., 78, 326.
HERBA, M.J., ILLESCAS, F.F., THIRLWELL, M.P. & 4 others (1988).
Hepatic malignancies: improved treatment with intraarterial Y-
90. Radiology, 169, 311.1034 J.H. ANDERSON et al.
KAPLAN, W.D., ENSMINGER, W.D., COME, S.E. & 5 others (1980).
Radionuclide angiography to predict patient response to hepatic
artery chemotherapy. Cancer Treat. Rep., 64, 1217.
KATO, T., NEMOTO, R., MORI, H., TAKAHASHI, M. & HARADA, M.
(1981). Arterial chemoembolisation with mitomycin C microcap-
sules in the treatment of primary or secondary carcinoma of the
kidney, liver bone and intrapelvic organs. Cancer, 48, 674.
KIM, D.K., WATSON, R.C, PANKE, L.D. & FORTNER, J.G. (1977).
Tumor vascularity as a prognostic factor for hepatic tumors.
Ann. Surg., 185, 31.
McARDLE, C.S., LEWI, H., HANSELL, D., KERR, D.J., MCKILLOP, J.
& WILLMOTT, N. (1988). Cytotoxic-loaded albumin microspheres:
a novel-approach to regional chemotherapy. Br. J. Surg., 75, 132.
MALIK, A.B., KAPLAN, J.E & SABA, T.M. (1976). Reference sample
method for cardiac output and regional blood flow determina-
tions in the rat. J. Appl. Physiol., 40, 472.
MEADE, V.M., BURTON, M.A., GRAY, B.N. & SELF, G.W. (1987).
Distribution ofdifferent sized microspheres in experimental hepa-
tic tumours. Eur. J. Cancer Clin. Oncol., 23, 37.
WILLMOTT, N., CUMMINGS, J., STUART, J.F.B. & FLORENCE, A.T.
(1985). Adriamycin-loaded albumin microspheres: in vivo distri-
bution and drug release rate in the rat. Biopharm. Drug Dispos.,
6, 91.
WILLMOTT, N., YAN CHEN, GOLDBERG, J., MCARDLE, C.S. &
FLORENCE, A.T. (1989). Biodegradation rate of embolised pro-
tein microspheres in lung, liver and kidney of rats. J. Pharm.
Pharmacol., 41, 433.